These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36373225)

  • 1. Barriers and facilitators to colonoscopy for cancer detection: patient and practitioner perspectives.
    Travis E; Kerrison RS; O'Connor DB; Ashley L
    Psychol Health; 2024 Sep; 39(9):1263-1283. PubMed ID: 36373225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to colonoscopy following fecal immunochemical test screening for colorectal cancer: A key informant interview study.
    Kerrison RS; Travis E; Dobson C; Whitaker KL; Rees CJ; Duffy SW; von Wagner C
    Patient Educ Couns; 2022 Jun; 105(6):1652-1662. PubMed ID: 34607734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 4. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to colonoscopy in UK colorectal cancer screening programmes: Qualitative interviews with ethnic minority groups.
    Kerrison RS; Gil N; Travis E; Jones R; Whitaker KL; Rees C; Duffy S; von Wagner C
    Psychooncology; 2023 May; 32(5):779-792. PubMed ID: 36929590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
    Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
    J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
    [No Abstract]   [Full Text] [Related]  

  • 7. Identifying barriers to colonoscopy screening for nonadherent African American participants in a patient navigation intervention.
    Sly JR; Edwards T; Shelton RC; Jandorf L
    Health Educ Behav; 2013 Aug; 40(4):449-57. PubMed ID: 23086556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived Deterrence Towards Colonoscopy for Colorectal Cancer Screening among Northern Malaysia Population: A Qualitative Study.
    Mohd Suan MA; Tan WL; Ismail I; Abu Hassan MR
    Asian Pac J Cancer Prev; 2020 May; 21(5):1253-1258. PubMed ID: 32458630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study.
    Bie AKL; Brodersen J
    Scand J Prim Health Care; 2018 Sep; 36(3):262-271. PubMed ID: 30238859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients.
    Schneider JL; Rivelli JS; Gruss I; Petrik AF; Nielson CM; Green BB; Coronado GD
    Am J Health Behav; 2020 Jul; 44(4):460-472. PubMed ID: 32553027
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to colorectal cancer screening in Vietnamese Americans: a qualitative analysis.
    Kimura A; Sin MK; Spigner C; Tran A; Tu SP
    J Cancer Educ; 2014 Dec; 29(4):728-34. PubMed ID: 24756545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of high quality assurance measures in bowel cancer screening on patient satisfaction of colonoscopy.
    Sarkar S; Athwal V; Sturgess RP; Lythgoe D; Bodger K
    J Gastrointestin Liver Dis; 2012 Sep; 21(3):251-8. PubMed ID: 23012665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer patients can be advocates for colorectal cancer screening for their siblings: A study on siblings' perspectives.
    Tan KK; Lim TZ; Chew E; Chow WM; Koh GC
    Psychooncology; 2020 Dec; 29(12):2028-2032. PubMed ID: 32715510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
    Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
    BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxieties should not be forgotten when screening relatives of colorectal cancer patients by colonoscopy.
    Williams GL; Clarke P; Vellacott KD
    Colorectal Dis; 2006 Nov; 8(9):781-4. PubMed ID: 17032325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators of implementing a multicomponent intervention to improve faecal immunochemical test (FIT) colorectal cancer screening in primary care clinics, Alberta.
    Adhikari K; Mah SS; Patterson M; Teare GF; Manalili K
    BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38802268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using specialist screening practitioners (SSPs) to increase uptake of bowel scope (flexible sigmoidoscopy) screening: results of a feasibility single-stage phase II randomised trial.
    McGregor LM; Skrobanski H; Ritchie M; Berkman L; Miller H; Freeman M; Patel N; Morris S; Rees C; von Wagner C
    BMJ Open; 2019 Feb; 9(2):e023801. PubMed ID: 30772850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.